Inflammation & Allergy - Drug Targets (Discontinued)
Title:Editorial: [A Threat to One is a Threat to All – Biosecurity for the Western World Starts in Developing Countries: Do We Speak the Same Language of Hygiene?]
Volume: 11 Issue: 5
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
S. Zaenker Kurt, Editorial: [A Threat to One is a Threat to All – Biosecurity for the Western World Starts in Developing Countries: Do We Speak the Same Language of Hygiene?], Inflammation & Allergy - Drug Targets (Discontinued) 2012; 11 (5) . https://dx.doi.org/10.2174/187152812803251015
DOI https://dx.doi.org/10.2174/187152812803251015 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Umbilical IgE and Advanced Glycation Products in Association with Allergies in Childhood
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Chemoprevention of Colorectal Cancer: Ready for Routine Use?
Current Topics in Medicinal Chemistry Quantum Dot-Encoded Beads for Ultrasensitive Detection
Recent Patents on Nanotechnology Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut
Current Protein & Peptide Science Enhancement of Dissolution Profile of Poorly Water Soluble Drugs by Using Techniques of Nanocrystallization
Current Nanomedicine Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar
Current Vascular Pharmacology Inflammation and Pancreatic Cancer: Recent Development with Focusing on Potential New Drug Targets
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets An Easy Approach to the Synthesis of New Fused 3-Aryl-5- trifluoromethyl-7,8-dihydro-6H-thieno [2,1-f] [1,2] thiazine 1-Oxide System
Letters in Organic Chemistry A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Current Vascular Pharmacology The Breath of Life: Recent Patents on Placental and Amnion Derived Cells for Treatment of Bronchopulmonary Dysplasia
Recent Patents on Regenerative Medicine VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Cytotoxicity and Anti-inflammatory Activity of Flavonoid Derivatives Targeting NF-kappaB
Recent Patents on Inflammation & Allergy Drug Discovery Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8<sup>+</sup> T Cells
Current Cancer Drug Targets Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?
Current Medicinal Chemistry Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design Estrogen, Immunity & Autoimmune Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Cutaneous Markers of HIV Infection and Progression
Current HIV Research Fractional Flow Reserve: Physiological Basis, Advantages and Limitations, and Potential Gender Differences
Current Cardiology Reviews Renal Involvement in H Syndrome, A Rare Cause of Diabetes Mellitus: Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets